mpd-rc 112 trial of pegylated interferon alpha-2a for polycythemia vera & essential thrombocythemia
Published 7 years ago • 495 plays • Length 1:59Download video MP4
Download video MP3
Similar videos
-
3:14
interim results of pegylated interferon alpha-2a for polycythemia vera and essential thrombocythemia
-
2:28
proud-pv and mpd-rc 112 trials of interferon alpha vs hydroxyurea for mpns
-
3:09
pegylated interferon for the treatment of polycythemia vera and essential thrombocythemia
-
2:05
ropeg in polycythemia vera: long-term proud-pv and conti-pv results
-
2:14
risk-adapted treatment of et & pv
-
3:00
ropeginterferon alpha-2b as an effective treatment against pv
-
1:29
ropeginterferon alfa-2b for polycythemia vera: impacts and considerations
-
6:49
the role of interferon in polycythemia vera & perspectives on the management of low-risk patients
-
10:56
identifying and communicating your polycythemia vera (pv) symptoms
-
3:12
diagnosed early in life with polycythemia vera: todd’s mpn story
-
5:19
hematology mindray bc-11 ups auto analyzer
-
2:16
ropeginterferon vs standard therapy for polycythemia vera
-
2:25
interferons in the treatment of mpns: clinical trials in 2021
-
2:55
interferons and myeloproliferative neoplasms (mpns)
-
1:49
current and future therapies for pv: ropeginterferon alfa-2b
-
0:48
highlights from mpn sessions
-
3:10
the stories behind the advances in polycythemia vera
-
0:55
the effect of vorinostat on methylation age in mpn patients
-
4:00
update on clinical trials for myeloproliferative neoplasms
-
2:55
pv-aim: using machine learning to predict resistance to hydroxyurea therapy in patients with pv
-
3:16
the importance of early intervention in young patients with mpns & the role of interferon therapy
-
3:19
targeting jak2 v617f vaf in polycythemia vera & the efficacy of ropeginterferon alfa-2b